SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15106801
Source:
http://linkedlifedata.com/resource/pubmed/id/15106801
Search
Subject
(
61
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0001721
,
umls-concept:C0005823
,
umls-concept:C0019425
,
umls-concept:C0332453
,
umls-concept:C1413516
pubmed:issue
1
pubmed:dateCreated
2004-4-26
pubmed:abstractText
It has been suspected that the mast cell chymase gene (CMA1) is important for the generation of angiotensin II and therefore might be associated with the pathogenesis of hypertension.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8306882
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/CMA1 protein, human
,
http://linkedlifedata.com/resource/pubmed/chemical/Chymases
,
http://linkedlifedata.com/resource/pubmed/chemical/Serine Endopeptidases
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0263-6352
pubmed:author
pubmed-author:InamotoNozomuN
,
pubmed-author:IwaiNaoharuN
,
pubmed-author:KokuboYoshihiroY
,
pubmed-author:MannamiToshifumiT
,
pubmed-author:ShiojiKeisukeK
,
pubmed-author:YouW TWT
pubmed:issnType
Print
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
103-9
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:15106801-Aged
,
pubmed-meshheading:15106801-Aged, 80 and over
,
pubmed-meshheading:15106801-Antihypertensive Agents
,
pubmed-meshheading:15106801-Blood Pressure
,
pubmed-meshheading:15106801-Chymases
,
pubmed-meshheading:15106801-Cohort Studies
,
pubmed-meshheading:15106801-Diastole
,
pubmed-meshheading:15106801-Female
,
pubmed-meshheading:15106801-Genetic Predisposition to Disease
,
pubmed-meshheading:15106801-Heterozygote
,
pubmed-meshheading:15106801-Humans
,
pubmed-meshheading:15106801-Hypertension
,
pubmed-meshheading:15106801-Japan
,
pubmed-meshheading:15106801-Linkage Disequilibrium
,
pubmed-meshheading:15106801-Male
,
pubmed-meshheading:15106801-Middle Aged
,
pubmed-meshheading:15106801-Point Mutation
,
pubmed-meshheading:15106801-Polymorphism, Single Nucleotide
,
pubmed-meshheading:15106801-Promoter Regions, Genetic
,
pubmed-meshheading:15106801-Serine Endopeptidases
,
pubmed-meshheading:15106801-Statistics as Topic
,
pubmed-meshheading:15106801-Systole
,
pubmed-meshheading:15106801-Transcription, Genetic
,
pubmed-meshheading:15106801-Treatment Outcome
pubmed:year
2004
pubmed:articleTitle
Heterozygous disruption of CMA1 does not affect blood pressure.
pubmed:affiliation
National Cardiovascular Center, Suita, Osaka, Japan.
pubmed:publicationType
Journal Article
,
Comparative Study
,
Research Support, Non-U.S. Gov't